ZIYLO
Ziylo's mission is to help people with diabetes to live more normal and longer lives. Using its back ground in supramolecular chemistry the company has developed a third ‘biomimetic’ class of glucose binding molecule (GBM). These molecules are at the core of medical devices such as Continuous Glucose Monitors (CGM) and therapeutics such as Glucose Responsive Insulins (GRI). The platform is based on over 20 years of cutting-edge research pioneered by Professor Anthony Davis’ group at the Un... iversity of Bristol. Inspired by nature's carbohydrate-binding molecules (lectins), Professor Davis has become a leader in the field of ‘Synthetic Lectins’ – biomimetic molecules that bind carbohydrates like glucose in blood. This award-winning chemistry has been published in Science and Nature Chemistry and has laid the foundation for the discovery the Biomimetic GBM platform.
ZIYLO
Industry:
Diabetes Health Care Medical Device Therapeutics
Founded:
2014-05-14
Address:
Bristol, Bristol, City Of, United Kingdom
Country:
United Kingdom
Website Url:
http://www.ziylo.com
Total Employee:
11+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
1000 K GBP
Technology used in webpage:
SPF Google Apps For Business Google Maps GoDaddy DNS Google Maps API Gravatar Profiles Digital Ocean Hub Network Services
Founder
Investors List
University of Bristol
University of Bristol investment in Series A - Ziylo
Official Site Inspections
http://www.ziylo.com
- Host name: 178.62.23.66
- IP address: 178.62.23.66
- Location: London United Kingdom
- Latitude: 51.5353
- Longitude: -0.6658
- Timezone: Europe/London
- Postal: SL1
